Metropolis Healthcare Ltd
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.
- Market Cap ₹ 8,908 Cr.
- Current Price ₹ 1,740
- High / Low ₹ 1,935 / 1,209
- Stock P/E 71.8
- Book Value ₹ 194
- Dividend Yield 0.46 %
- ROCE 17.4 %
- ROE 15.6 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 24.1%
Cons
- Stock is trading at 8.98 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
223 | 254 | 349 | 405 | 485 | 581 | 665 | 961 | 1,157 | 1,066 | 1,076 | |
159 | 183 | 263 | 289 | 348 | 434 | 489 | 677 | 833 | 792 | 823 | |
Operating Profit | 64 | 71 | 86 | 115 | 137 | 148 | 176 | 285 | 324 | 274 | 252 |
OPM % | 29% | 28% | 25% | 29% | 28% | 25% | 26% | 30% | 28% | 26% | 23% |
15 | 6 | 39 | 30 | 15 | 20 | 5 | 12 | 32 | 21 | 19 | |
Interest | 2 | 2 | 1 | 2 | 3 | 3 | 10 | 11 | 25 | 31 | 23 |
Depreciation | 8 | 10 | 12 | 12 | 14 | 15 | 31 | 44 | 60 | 85 | 88 |
Profit before tax | 69 | 65 | 112 | 131 | 135 | 149 | 140 | 242 | 272 | 179 | 161 |
Tax % | 33% | 33% | 32% | 33% | 29% | 32% | 20% | 25% | 27% | 22% | |
46 | 43 | 76 | 88 | 96 | 101 | 112 | 183 | 200 | 139 | 124 | |
EPS in Rs | 47.12 | 43.64 | 79.59 | 92.21 | 100.34 | 20.22 | 22.13 | 35.73 | 38.99 | 27.13 | 24.22 |
Dividend Payout % | 3% | 0% | 101% | 57% | 0% | 66% | 36% | 22% | 21% | 29% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 17% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 2% |
TTM: | -9% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | -11% |
1 Year: | 37% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 23% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 254 | 296 | 233 | 258 | 354 | 405 | 502 | 655 | 829 | 926 | 982 |
16 | 10 | 4 | 0 | 0 | 17 | 54 | 111 | 377 | 268 | 231 | |
33 | 35 | 95 | 170 | 76 | 95 | 122 | 163 | 242 | 230 | 216 | |
Total Liabilities | 313 | 351 | 341 | 438 | 440 | 528 | 688 | 939 | 1,459 | 1,434 | 1,440 |
83 | 84 | 92 | 152 | 157 | 163 | 216 | 307 | 1,005 | 1,066 | 1,093 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 6 | 3 | 0 | 6 | 20 | 0 |
Investments | 148 | 175 | 120 | 143 | 98 | 135 | 130 | 12 | 50 | 50 | 73 |
82 | 92 | 129 | 143 | 185 | 224 | 340 | 620 | 398 | 299 | 274 | |
Total Assets | 313 | 351 | 341 | 438 | 440 | 528 | 688 | 939 | 1,459 | 1,434 | 1,440 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
52 | 43 | 75 | 77 | 74 | 56 | 156 | 236 | 244 | 238 | |
-39 | -36 | 101 | -67 | 19 | -4 | -51 | 59 | -736 | 47 | |
-10 | -10 | -165 | -17 | -82 | -64 | -46 | -31 | 172 | -288 | |
Net Cash Flow | 3 | -3 | 11 | -6 | 12 | -12 | 59 | 264 | -320 | -3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 50 | 60 | 50 | 56 | 62 | 74 | 68 | 50 | 44 | 43 |
Inventory Days | 49 | 50 | 42 | 35 | 49 | 52 | 38 | 57 | 66 | 64 |
Days Payable | 64 | 71 | 84 | 93 | 87 | 95 | 155 | 143 | 131 | 133 |
Cash Conversion Cycle | 34 | 38 | 7 | -1 | 24 | 31 | -48 | -36 | -22 | -26 |
Working Capital Days | 60 | 48 | 12 | -47 | 43 | 57 | 29 | 16 | 23 | 24 |
ROCE % | 22% | 37% | 50% | 43% | 38% | 35% | 38% | 28% | 17% |
Documents
Announcements
- Disclosure Under Regulation 30 Of SEBI (LODR), Regulations 2015 ('Listing Regulations') 17m
-
Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015.
2d - Compliance Certificate for the financial year ended March 31, 2024.
- Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2024 2d
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Apr - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
13 Apr - Of allotment of equity shares under Metropolis Healthcare Limited Restrictive Stock Unit Plan -2020
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Mar 2021Transcript PPT
-
Nov 2020TranscriptPPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptPPT
-
Aug 2020Transcript PPT
-
May 2020Transcript PPT
-
Mar 2020TranscriptPPT
-
Feb 2020Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Sep 2019TranscriptPPT
-
Aug 2019Transcript PPT
-
Aug 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
May 2019Transcript PPT
Leading Diagnostics company[1] Metropolis Healthcare Ltd is the second largest Diagnostic company in India and the largest player in Western and Southern India.